Research ArticleArticle
Evaluation of Expression and Glycosylation Status of UGT1A10 in Supersomes and Intestinal Epithelial Cells with a Novel Specific UGT1A10 Monoclonal Antibody
Shingo Oda, Yukiko Kato, Masahiko Hatakeyama, Atsushi Iwamura, Tatsuki Fukami, Toshiyuki Kume, Tsuyoshi Yokoi and Miki Nakajima
Drug Metabolism and Disposition September 2017, 45 (9) 1027-1034; DOI: https://doi.org/10.1124/dmd.117.075291
Shingo Oda
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Yukiko Kato
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Masahiko Hatakeyama
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Atsushi Iwamura
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Tatsuki Fukami
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Toshiyuki Kume
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Tsuyoshi Yokoi
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Miki Nakajima
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (S.O., Y.K., T.F., T.Y., M.N.); CLEA Japan, Fujinomiya, Japan (M.H.); DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (A.I.); and Discovery Technology Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan (T.K.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Evaluation of UGT1A10 protein in human tissues
Shingo Oda, Yukiko Kato, Masahiko Hatakeyama, Atsushi Iwamura, Tatsuki Fukami, Toshiyuki Kume, Tsuyoshi Yokoi and Miki Nakajima
Drug Metabolism and Disposition September 1, 2017, 45 (9) 1027-1034; DOI: https://doi.org/10.1124/dmd.117.075291
Research ArticleArticle
Evaluation of UGT1A10 protein in human tissues
Shingo Oda, Yukiko Kato, Masahiko Hatakeyama, Atsushi Iwamura, Tatsuki Fukami, Toshiyuki Kume, Tsuyoshi Yokoi and Miki Nakajima
Drug Metabolism and Disposition September 1, 2017, 45 (9) 1027-1034; DOI: https://doi.org/10.1124/dmd.117.075291
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement